{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:18:04Z","timestamp":1792145884278,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pharep.2015.04.004","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T09:44:48Z","timestamp":1429955088000},"page":"1124-1129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Valproic acid (VPA) reduces sensorimotor gating deficits and HDAC2 overexpression in the MAM animal model of schizophrenia"],"prefix":"10.1007","volume":"67","author":[{"given":"Ewelina","family":"Bator","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Latusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Radaszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"W\u0119dzony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Ma\u0107kowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"10.1016\/j.pharep.2015.04.004_bib0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/npp.2012.86","article-title":"The role of histone acetylation in memory formation and cognitive impairments","volume":"38","author":"Peixoto","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2015.04.004_bib0165","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1038\/tp.2011.61","article-title":"Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders","volume":"1","author":"Tang","year":"2011","journal-title":"Transl Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2015.04.004_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2007.09.020","article-title":"Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection","volume":"98","author":"Sharma","year":"2008","journal-title":"Schizophr Res"},{"issue":"15","key":"10.1016\/j.pharep.2015.04.004_bib0175","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1523\/JNEUROSCI.0079-12.2012","article-title":"HDAC1 regulates fear extinction in mice","volume":"32","author":"Bahari-Javan","year":"2012","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.pharep.2015.04.004_bib0180","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nn.3181","article-title":"HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity","volume":"15","author":"Kurita","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharep.2015.04.004_bib0185","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropharm.2012.11.015","article-title":"An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy","volume":"68","author":"Millan","year":"2013","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.pharep.2015.04.004_bib0190","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1017\/S1461145711001672","article-title":"Exposure to enriched environments during adolescence prevents abnormal behaviours associated with histone deacetylation in phencyclidine-treated mice","volume":"15","author":"Koseki","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.004_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.euroneuro.2013.05.013","article-title":"Prenatal MAM administration affects histone H3 methylation in postnatal life in the rat medial prefrontal cortex","volume":"24","author":"Mackowiak","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.004_bib0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/bdrc.21052","article-title":"Animal models of brain maldevelopment induced by cycad plant genotoxins","volume":"99","author":"Kisby","year":"2013","journal-title":"Birth Defects Res C: Embryo Today"},{"issue":"11","key":"10.1016\/j.pharep.2015.04.004_bib0205","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/sj.npp.1300516","article-title":"Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens","volume":"29","author":"Flagstad","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.004_bib0210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/sj.npp.1300625","article-title":"Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia","volume":"30","author":"Flagstad","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.004_bib0215","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuroscience.2006.08.004","article-title":"Peri-pubertal maturation after developmental disturbance: a model for psychosis onset in the rat","volume":"143","author":"Le Pen","year":"2006","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.004_bib0220","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsych.2006.01.003","article-title":"A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia","volume":"60","author":"Moore","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.pharep.2015.04.004_bib0225","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.pharep.2015.04.004_bib0230","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"39","key":"10.1016\/j.pharep.2015.04.004_bib0235","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.004_bib0240","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.pharep.2015.04.004_bib0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","article-title":"Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling","volume":"30","author":"Guidotti","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.004_bib0250","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-008-1072-4","article-title":"Realistic expectations of prepulse inhibition in translational models for schizophrenia research","volume":"199","author":"Swerdlow","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pharep.2015.04.004_bib0255","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.105.090845","article-title":"An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition","volume":"315","author":"Ong","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"10.1016\/j.pharep.2015.04.004_bib0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejphar.2006.09.050","article-title":"Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice","volume":"553","author":"Umeda","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharep.2015.04.004_bib0265","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S1734-1140(13)71469-5","article-title":"MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex","volume":"65","author":"Mackowiak","year":"2013","journal-title":"Pharmacol Rep"},{"issue":"1","key":"10.1016\/j.pharep.2015.04.004_bib0270","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.npp.1300023","article-title":"Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia","volume":"28","author":"Casey","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pharep.2015.04.004_bib0275","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hup.1236","article-title":"Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia","volume":"26","author":"Larrison","year":"2011","journal-title":"Hum Psychopharmacol"},{"issue":"2\u20133","key":"10.1016\/j.pharep.2015.04.004_bib0280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s002130100799","article-title":"Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges","volume":"156","author":"Swerdlow","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"13","key":"10.1016\/j.pharep.2015.04.004_bib0285","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kramer","year":"2003","journal-title":"EMBO J"},{"issue":"26","key":"10.1016\/j.pharep.2015.04.004_bib0290","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7\u20138","key":"10.1016\/j.pharep.2015.04.004_bib0295","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","article-title":"Epigenetic GABAergic targets in schizophrenia and bipolar disorder","volume":"60","author":"Guidotti","year":"2011","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2015.04.004_bib0300","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.pharep.2015.04.004_bib0305","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/mol.110.067702","article-title":"Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases","volume":"79","author":"Huang","year":"2011","journal-title":"Mol Pharmacol"},{"issue":"42","key":"10.1016\/j.pharep.2015.04.004_bib0310","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1523\/JNEUROSCI.3272-07.2007","article-title":"Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters","volume":"27","author":"Huang","year":"2007","journal-title":"J Neurosci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114015000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:02Z","timestamp":1752611762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2015.04.004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1734114015000730"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2015.04.004","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid (VPA) reduces sensorimotor gating deficits and HDAC2 overexpression in the MAM animal model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2015.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}